The page lists 26 projects related to the topic "cirrhosis".
# | |||
---|---|---|---|
1 | EPoS | Elucidating Pathways of Steatohepatitis | 2015 |
2 | CARBALIVE | Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease. | 2015 |
3 | FLDcure | A potent Micro-RNA therapeutic for nonalcoholic fatty liver disease (NAFLD) | 2015 |
4 | TARGEPILIVER | Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs. | 2015 |
5 | REZONABLE | Regeneration and zonation by ZEB2 of Liver Endothelium | 2016 |
6 | EPIRIN | EPIGENETIC REGULATION OF INFLAMMATION IN NAFLD | 2015 |
7 | HBV1 | Innate immune responses to human hepatotropic viral infections | 2015 |
8 | HEPCIR | Cell circuits as targets and biomarkers for liver disease and cancer prevention | 2016 |
9 | GALAXY | GALAXY: Gut-and-liver axis in alcoholic liver fibrosis | 2016 |
10 | CollBioImag | Development of a cell-based system for high-throughput screening of antifibrotics | 2016 |
11 | RADIcAL | Non-invasive rapid assessment of chronic liver disease using Magnetic Resonance Imaging with LiverMultiScan | 2016 |
12 | TGDNL | Mechanisms of cellular fatty acid homeostasis | 2017 |
13 | Foie Gras | Bioenergetic Remodeling in the Pathophysiology and Treatment of Non-Alcoholic Fatty Liver Disease | 2017 |
14 | mtFOIE GRAS | mitoFOIE GRAS: Non-invasive Profiling of Mitochondrial Function in Non-Alcoholic Fatty Liver Disease | 2017 |
15 | LIVERHOPE | SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS | 2017 |
16 | SULIPRO | A scientifically proven, safe, naturally derived drug for the effective treatment of liver damage - an innovative solution for a significant unmet medical need | 2017 |
17 | LIVERZAP | Live, In vivo Visualisation of liver Regeneration in Zebrafish After Photoablation of hepatocytes | 2018 |
18 | NAFLDcure | A novel pharmaceutical treatment for nonalcoholic fatty liver disease | 2017 |
19 | HEPASPHER | Mimicking liver disease and regeneration in vitro for drug development and liver transplantation | 2017 |
20 | New Chol | Development of New therapies against cholangiopathies. | 2017 |
21 | HIPShot | HBV GenetIc and Proteomic Screen | 2019 |
22 | MICROB-PREDICT | MICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response | 2019 |
23 | WineALaCarte | Commercial appliance for an on-demand & custom reduction of alcohol in wine | 2019 |
24 | MyeFattyLiver | Unravelling the heterogeneity and functions of hepatic myeloid cells in Non-Alcoholic Fatty Liver Disease | 2019 |
25 | DECISION | DECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEMS APPROACHES | 2020 |
26 | LiverScreen | Screening for liver fibrosis - population-based study across European countries | 2020 |